AI Technology Boosts Breast Cancer Detection by 20%: Study

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on email

According to a groundbreaking study published in The Lancet Oncology, artificial intelligence (AI) has demonstrated its potential to significantly improve the detection of breast cancers compared to standard screening methods conducted by radiologists. The research, conducted in Sweden, involved testing 80,000 eligible women for mammograms, revealing that AI technology increased the detection rate by an impressive 20% while also reducing the workload for radiologists by about 44%. 

In the study, AI technology was found to detect 244 screen-detected cancers, surpassing the 203 cancers detected through conventional screening methods. Additionally, AI technology resulted in 861 recalls, compared to 817 recalls from traditional methods. These results suggest that AI can play a vital role in enhancing the efficiency and accuracy of breast cancer detection, thereby potentially improving patient outcomes. 

The AI detection rates exhibited in the study stood at 6 per 1,000 women screened, a figure that was deemed “above the lowest acceptable limit for safety.” In comparison, conventional screening methods yielded a detection rate of 5 per 1,000 women screened. Although the false positive rate for both AI-supported screening and normal methods remained similar at 1.5%, the considerable increase in cancer detection through AI suggests that the benefits of improved sensitivity outweigh the slight rise in false positives. 

An essential aspect of this study’s findings was the significant relief AI provided to radiologists by reducing their screen-reading workload by 44%. Given the reported shortage of radiologists, this alleviation could be instrumental in enhancing the efficiency of breast cancer screening programs. As Dr. Kristina Lang, the lead author of the study, pointed out, AI’s primary potential lies in allowing radiologists to focus on more advanced diagnostics and patient care while shortening waiting times for patients. 

Dr. Lang stated that although further research is necessary to fully understand the use of AI in mammograms, the technology undoubtedly possesses the potential to strengthen future mammogram screenings. By incorporating AI into the breast cancer screening process, the burden of excessive reading can be lifted off radiologists, enabling them to provide more accurate and timely diagnoses to patients. Dr. Stamatia Destounis, a radiologist with Elizabeth Wende Breast Care in Rochester, New York, emphasized the significance of this breakthrough.

Early detection of breast cancer is critical to improving patient prognosis, and any technology that enhances accuracy is indeed a significant advancement. The implementation of AI in mammography does not seek to replace radiologists entirely but aims to augment their abilities and streamline the screening process. The study highlighted that while AI-supported screening systems would require at least one radiologist in charge of detection, they could potentially eliminate the need for double reading the majority of mammograms, thus further reducing the strain on radiologists’ workloads. 

AI’s incorporation into breast cancer screening has the potential to revolutionize mammography and improve healthcare outcomes for women worldwide. By augmenting radiologists’ capabilities and efficiency, this technology promises to enhance the accuracy of breast cancer detection, reduce unnecessary recalls, and ultimately save lives by identifying malignancies at earlier stages. 

However, it is essential to approach the integration of AI in medical practices cautiously. Further research and rigorous testing are required to validate the technology’s efficacy and safety fully. Additionally, healthcare professionals must be trained to use AI effectively and interpret its outputs accurately. 

As the first trial exploring the potential of AI in mammograms, this study marks a critical step forward in the application of AI in radiology. With ongoing advancements and continued research, the future of breast cancer screening holds great promise, offering improved accuracy, efficiency, and patient outcomes. As the medical community gains a deeper understanding of AI’s capabilities, it will likely become an indispensable tool in the fight against breast cancer and other diseases, heralding a new era in healthcare. 

Leave a Reply


Free CME credits

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

Digital Certificate PDF

On course completion, you will receive a full-sized presentation quality digital certificate.

medtigo Simulation

A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

medtigo Points

medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
  • Registration with medtigo = 10 points
  • 1 visit to medtigo’s website = 1 point
  • Interacting with medtigo posts (through comments/clinical cases etc.) = 5 points
  • Attempting a game = 1 point
  • Community Forum post/reply = 5 points

    *Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.

All Your Certificates in One Place

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.

Our Certificate Courses